Other – Page 9 – Safe Biologics

ASBM Presents to Nashville Pharmacy Students, Healthcare Practitioners

May 20, 2016

On Wednesday, June 15th, ASBM presented a one-hour educational program entitled “Biosimilars: New Choices, New Challenges” at TriStar Centennial Medical Center in Nashville, TN. Tristar Centennial educates pharmacy students from Belmont University, Lipscomb University, Murray State University, and the University of Tennessee, and the audience was comprised of 20 pharmacy students from these schools as well as nurse-practitioners […]

ASBM Presents to Nashville Pharmacy Students, Healthcare Practitioners

May 20, 2016

On Wednesday, June 15th, ASBM presented a one-hour educational program entitled “Biosimilars: New Choices, New Challenges” at TriStar Centennial Medical Center in Nashville, TN. Tristar Centennial educates pharmacy students from Belmont University, Lipscomb University, Murray State University, and the University of Tennessee, and the audience was comprised of 20 pharmacy students from these schools as well as nurse-practitioners […]

ASBM Presents at Ohio State University Medical Center

May 12, 2016

On May 10th, ASBM cohosted an educational briefing on biosimilars with the Ohio State University College of Medicine at the University’s Wexner Medical Center in Columbus, OH. The audience was comprised of a broad cross section of stakeholders including patient advocates, physicians, pharmacists, representatives from the Ohio Pharmacy Association, The Ohio Nurses Association, a State Representative, medical […]

ASBM Presents to Rhode Island Pharmacists

April 1, 2016

On March 31st, the Alliance for Safe Biologic Medicines (ASBM) gave an educational presentation on biologics and biosimilars for 150 pharmacists attending the 31st annual Seminar by the Sea conference, held by the University of Rhode Island College of Pharmacy.

ASBM Presents to Rhode Island Pharmacists

April 1, 2016

On March 31st, the Alliance for Safe Biologic Medicines (ASBM) gave an educational presentation on biologics and biosimilars for 150 pharmacists attending the 31st annual Seminar by the Sea conference, held by the University of Rhode Island College of Pharmacy.

ASBM Argues for Distinguishable Naming at World Biosimilar Congress: Europe 2015

November 10, 2015

On November 10th, 2015 in Basel, Switzerland, ASBM’s Advisory Board Chair, University of Arizona pharmacy professor Philip J Schneider and ASBM Steering Committee Member Andrew Spiegel, Executive Director of the Global Colon Cancer Association, participated in a debate on the subject of distinguishable naming for biosimilars. The debate session, entitled “Naming conventions for biosimilar and […]

ASBM, Patient Groups Write Australia on Proposed Substitution Policy

July 6, 2015

On May 26, 2015 Australian Health Minister Sussan Ley announced that Australia would become the first nation in the world to allow so-called “automatic” substitution of biosimilars by pharmacists in place of the biologic prescribed by a physician. This move came at the recommendation of Australia’s Pharmacy Benefits Advisory Committee (PBAC). In response to this development, ASBM and several […]

ASBM Conducts CE Course for Pharmacists in CA

June 2, 2015

On May 29, 2015, in partnership with the Chapman University School of Pharmacy, ASBM held a Continuing Education course for roughly 40 pharmacists entitled “BIOSIMILARS: WHAT EVERY PHARMACIST SHOULD KNOW” at Chapman’s campus in Irvine, CA. Following a brief baseline quiz to determine the participants’ understanding of biologics and biosimilars, four presentations were given by […]

ASBM Conducts CE Course for Pharmacists in CA

June 2, 2015

On May 29, 2015, in partnership with the Chapman University School of Pharmacy, ASBM held a Continuing Education course for roughly 40 pharmacists entitled “BIOSIMILARS: WHAT EVERY PHARMACIST SHOULD KNOW” at Chapman’s campus in Irvine, CA. Following a brief baseline quiz to determine the participants’ understanding of biologics and biosimilars, four presentations were given by […]

Physician Confidence Critical to Biosimilar Adoption, Says Panel

June 1, 2015

SAN DIEGO, CA- On May 28, 2015 a panel discussion was held that examined the perspectives of innovator companies, biosimilar manufacturers, biotechnology reporters, and the health provider community on the topic of biosimilar development and marketing. The panel was held in as part of the World Biosimilar Congress 2015. ASBM chairman Dr.Harry Gewanter provided the […]